Save the Date: November 17th, 2016 at 2:00 pm and 7:00 pm

Don't miss this fantastic opportunity. On November 17, 2016 Matthias Hackl, CEO and Co-founder, TAmiRNA GmbH will give a webinar lecture entitled “OsteomiRs – circulating microRNA biomarkers for osteoporosis". In the webinar he will discuss the pre-analytical standards, quality checks and normalization required for robust microRNA analysis in serum. Dr. Hackl will show how TAmiRNA have used Exiqon’s microRNA qPCR system to develop a non-invasive serum microRNA test for osteoporosis. 

There is an urgent clinical need to improve early diagnosis of osteoporosis, since the available screening tools lack sufficient specificity and sensitivity for early detection. This is likely due to the fact that osteoporosis is a multifactorial disease, including skeletal as well as extra-skeletal risk factors. We believe that we can improve early diagnosis of osteoporosis on the basis of circulating microRNAs derived from bone, muscle, immune and other cells in the body. Dr Hackl says “Our ultimate goal is to identify a signature of circulating microRNAs that is predictive of fracture-risk due to osteoporosis.”  Register for the webinar to hear how robust microRNA analysis can be achieved from even the most challenging samples using the miRCURY LNA™ Universal RT microRNA PCR System.